W.ChangY
Abbreviations AD: Alzheimers disease BBB: bloodbrain barrier GLP-1: glucagon-like peptide-1 GLP-1R(s): GLP-1 receptor(s) GLP-1RA(s): GLP-1 receptor agonists NDD: neurodegenerative diseases PD: Parkinsons disease T2DM: type 2 diabetes mellitus REFERENCES Knudsen LB, Lau J (2019) The Discovery and Development of Liraglutide and Semaglutide
In addition, less than 10% of subjects may experience rashes, fatigue, other gastrointestinal problems, and reactions at the injection site, such as pain, bleeding, redness, swelling, or itching
doi: 10.1371/journal.pone.0158205 232 ChenSSunJZhaoGGuoAChenYFuRet al
To Maintain Weight Loss Microdosing is common after patients have used higher doses of a GLP-1 to reach their target weight in order to help with weight maintenance, says Sharon Giese, MD, a New York City plastic surgeon who has been prescribing GLP-1s since 2022
While the study missed its primary endpoint it reported a reduction in heavy alcohol consumption among participants with obesity (Klausen Jensen Mller)
